v3.26.3
Segments (Tables)
9 Months Ended
Sep. 30, 2026
Segments [Abstract]  
Segment Data Segment data for the three months ended September 30, 2026 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

457,403 

$

233,537 

$

690,940 

$

-

$

690,940 

Cost of services provided and goods sold

(excluding depreciation)

Wages

257,425 

78,411 

335,836 

-

335,836 

Patient care expense

48,205 

-

48,205 

-

48,205 

Other expenses

36,363 

37,574 

73,937 

-

73,937 

Total cost of services provided and goods sold

341,993 

115,985 

457,978 

-

457,978 

Selling, general and administrative expense

Wages

16,710 

23,102 

39,812 

5,090 

44,902 

Advertising

-

23,885 

23,885 

-

23,885 

Stock compensation

-

-

-

9,135 

9,135 

Other expenses

6,390 

24,046 

30,436 

3,111 

33,547 

Total selling, general and administrative expense

23,100 

71,033 

94,133 

17,336 

111,469 

Depreciation

5,791 

8,624 

14,415 

12 

14,427 

Amortization

25 

2,949 

2,974 

-

2,974 

Other operating expense

7,352 

88 

7,440 

230 

7,670 

Total costs and expenses

378,261 

198,679 

576,940 

17,578 

594,518 

Income/(loss) from operations

79,142 

34,858 

114,000 

(17,578)

96,422 

Interest expense

(54)

(145)

(199)

(1,898)

(2,097)

Intercompany interest income/(expense)

6,766 

4,574 

11,340 

(11,340)

-

Other income - net

124 

5 

129 

2,254 

2,383 

Income/(expense) before income taxes

85,978 

39,292 

125,270 

(28,562)

96,708 

Income taxes

(20,270)

(9,152)

(29,422)

4,362 

(25,060)

Net income/(loss)

$

65,708 

$

30,140 

$

95,848 

$

(24,200)

$

71,648 

Additions to long-lived assets

$

7,987 

$

73,703 

$

81,690 

$

6 

$

81,696 


‎

Segment data for the three months ended September 30, 2025 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

407,741 

$

217,159 

$

624,900 

$

-

$

624,900 

Cost of services provided and goods sold

(excluding depreciation)

Wages

239,357 

72,992 

312,349 

-

312,349 

Patient care expense

43,269 

-

43,269 

-

43,269 

Other expenses

35,389 

34,136 

69,525 

-

69,525 

Total cost of services provided and goods sold

318,015 

107,128 

425,143 

-

425,143 

Selling, general and administrative expense

Wages

16,904 

21,122 

38,026 

6,440 

44,466 

Advertising

-

19,542 

19,542 

-

19,542 

Stock compensation

-

-

-

5,851 

5,851 

Other expenses

8,332 

20,008 

28,340 

7,576 

35,916 

Total selling, general and administrative expense

25,236 

60,672 

85,908 

19,867 

105,775 

Depreciation

5,354 

8,298 

13,652 

12 

13,664 

Amortization

26 

2,544 

2,570 

-

2,570 

Other operating expense/(income)

3,036 

(38)

2,998 

-

2,998 

Total costs and expenses

351,667 

178,604 

530,271 

19,879 

550,150 

Income/(loss) from operations

56,074 

38,555 

94,629 

(19,879)

74,750 

Interest expense

(56)

(132)

(188)

(269)

(457)

Intercompany interest income/(expense)

5,685 

4,030 

9,715 

(9,715)

-

Other income - net

61 

25 

86 

9,165 

9,251 

Income/(expense) before income taxes

61,764 

42,478 

104,242 

(20,698)

83,544 

Income taxes

(14,993)

(10,407)

(25,400)

6,093 

(19,307)

Net income/(loss)

$

46,771 

$

32,071 

$

78,842 

$

(14,605)

$

64,237 

Additions to long-lived assets

$

10,850 

$

6,639 

$

17,489 

$

10 

$

17,499 


‎

Segment data for the first nine months ended September 30, 2026 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

1,320,762 

$

700,942 

$

2,021,704 

$

-

$

2,021,704 

Cost of services provided and goods sold

(excluding depreciation)

Wages

755,955 

238,744 

994,699 

-

994,699 

Patient care expense

141,158 

-

141,158 

-

141,158 

Other expenses

108,037 

107,613 

215,650 

-

215,650 

Total cost of services provided and goods sold

1,005,150 

346,357 

1,351,507 

-

1,351,507 

Selling, general and administrative expense

Wages

51,905 

68,647 

120,552 

15,094 

135,646 

Advertising

-

67,718 

67,718 

-

67,718 

Stock compensation

-

-

-

31,189 

31,189 

Other expenses

23,409 

69,970 

93,379 

13,061 

106,440 

Total selling, general and administrative expense

75,314 

206,335 

281,649 

59,344 

340,993 

Depreciation

17,484 

25,477 

42,961 

36 

42,997 

Amortization

78 

8,185 

8,263 

-

8,263 

Other operating expense

7,432 

78 

7,510 

230 

7,740 

Total costs and expenses

1,105,458 

586,432 

1,691,890 

59,610 

1,751,500 

Income/(loss) from operations

215,304 

114,510 

329,814 

(59,610)

270,204 

Interest expense

(158)

(466)

(624)

(3,774)

(4,398)

Intercompany interest income/(expense)

19,484 

13,661 

33,145 

(33,145)

-

Other income - net

285 

31 

316 

10,755 

11,071 

Income/(expense) before income taxes

234,915 

127,736 

362,651 

(85,774)

276,877 

Income taxes

(56,088)

(29,899)

(85,987)

14,763 

(71,224)

Net income/(loss)

$

178,827 

$

97,837 

$

276,664 

$

(71,011)

$

205,653 

Additions to long-lived assets

$

21,309 

$

126,760 

$

148,069 

$

31 

$

148,100 


‎

Segment data for the first nine months ended September 30, 2025 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

1,211,341 

$

679,300 

$

1,890,641 

$

-

$

1,890,641 

Cost of services provided and goods sold

(excluding depreciation)

Wages

716,335 

226,168 

942,503 

-

942,503 

Patient care expense

124,656 

-

124,656 

-

124,656 

Other expenses

110,475 

112,144 

222,619 

-

222,619 

Total cost of services provided and goods sold

951,466 

338,312 

1,289,778 

-

1,289,778 

Selling, general and administrative expense

Wages

51,188 

63,326 

114,514 

13,919 

128,433 

Advertising

-

56,654 

56,654 

-

56,654 

Stock compensation

-

-

-

27,668 

27,668 

Other expenses

25,673 

63,876 

89,549 

9,381 

98,930 

Total selling, general and administrative expense

76,861 

183,856 

260,717 

50,968 

311,685 

Depreciation

15,863 

24,899 

40,762 

36 

40,798 

Amortization

78 

7,635 

7,713 

-

7,713 

Other operating expense/(income)

3,155 

(80)

3,075 

-

3,075 

Total costs and expenses

1,047,423 

554,622 

1,602,045 

51,004 

1,653,049 

Income/(loss) from operations

163,918 

124,678 

288,596 

(51,004)

237,592 

Interest expense

(150)

(394)

(544)

(685)

(1,229)

Intercompany interest income/(expense)

16,436 

11,930 

28,366 

(28,366)

-

Other income - net

170 

58 

228 

13,742 

13,970 

Income/(expense) before income taxes

180,374 

136,272 

316,646 

(66,313)

250,333 

Income taxes

(45,353)

(32,344)

(77,697)

15,851 

(61,846)

Net income/(loss)

$

135,021 

$

103,928 

$

238,949 

$

(50,462)

$

188,487 

Additions to long-lived assets

$

22,234 

$

24,825 

$

47,059 

$

15 

$

47,074 

Identifiable Assets By Segment

September 30,

December 31,

2026

2025

VITAS

$

882,094 

$

784,927 

Roto-Rooter

652,773 

528,587 

Reportable segments

1,534,867 

1,313,514 

Corporate

183,572 

224,675 

Chemed consolidated

$

1,718,439 

$

1,538,189